Thomas S. Mchugh - Nov 29, 2022 Form 4 Insider Report for AVADEL PHARMACEUTICALS PLC (AVDL)

Role
Chief Financial Officer
Signature
/s/ Jerad G. Seurer, as Attorney-in-Fact
Stock symbol
AVDL
Transactions as of
Nov 29, 2022
Transactions value $
$39,000
Form type
4
Date filed
11/30/2022, 03:01 PM
Previous filing
May 31, 2022
Next filing
Jun 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVDL ADSs Purchase $39K +5K +6.99% $7.80 76.5K Nov 29, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts.